Seres Therapeutics released Q2 2026 results with a business update, but the initial statement did not disclose key financial figures or strategic details. Focus

Seres Therapeutics released Q2 2026 results with a business update, but the initial statement did not disclose key financial figures or strategic details. Focus now shifts to management’s webcast and updates on SER-155 after earlier positive trial data.